| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.9 |
| mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
-0.031 |
0.9 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.9 |